New Zealand markets closed

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
13.26+0.54 (+4.25%)
At close: 04:00PM EST
13.44 +0.18 (+1.36%)
After hours: 06:11PM EST
Full screen
Trade prices are not sourced from all markets
Previous close12.72
Open12.67
Bid12.53 x 800
Ask13.75 x 800
Day's range12.53 - 13.41
52-week range8.92 - 26.89
Volume216,701
Avg. volume550,520
Market cap597.33M
Beta (5Y monthly)1.60
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    BioLife Solutions Reports Third Quarter 2023 Financial Results

    BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and nine months of 2023.

  • PR Newswire

    BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023

    BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter financial results will be released after market close on Thursday, November 9, 2023. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business upda

  • PR Newswire

    BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023

    BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately. Rice has agreed to consult for the Company until March 31, 2024, to support a smooth transition.